1
|
Morii M, Fukumoto Y, Kubota S, Yamaguchi N, Nakayama Y, Yamaguchi N. Imatinib inhibits inactivation of the ATM/ATR signaling pathway and recovery from adriamycin/doxorubicin-induced DNA damage checkpoint arrest. Cell Biol Int 2015; 39:923-32. [DOI: 10.1002/cbin.10460] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2014] [Accepted: 03/06/2015] [Indexed: 01/16/2023]
Affiliation(s)
- Mariko Morii
- Department of Molecular Cell Biology; Graduate School of Pharmaceutical Sciences, Chiba University; Chiba 260-8675 Japan
| | - Yasunori Fukumoto
- Department of Molecular Cell Biology; Graduate School of Pharmaceutical Sciences, Chiba University; Chiba 260-8675 Japan
| | - Sho Kubota
- Department of Molecular Cell Biology; Graduate School of Pharmaceutical Sciences, Chiba University; Chiba 260-8675 Japan
| | - Noritaka Yamaguchi
- Department of Molecular Cell Biology; Graduate School of Pharmaceutical Sciences, Chiba University; Chiba 260-8675 Japan
| | - Yuji Nakayama
- Department of Molecular Cell Biology; Graduate School of Pharmaceutical Sciences, Chiba University; Chiba 260-8675 Japan
- Present address: Department of Biochemistry & Molecular Biology; Kyoto Pharmaceutical University; Kyoto 607-8414 Japan
| | - Naoto Yamaguchi
- Department of Molecular Cell Biology; Graduate School of Pharmaceutical Sciences, Chiba University; Chiba 260-8675 Japan
| |
Collapse
|